Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

1.13
Delayed Data
As of Sep 04
 -0.04 / -3.42%
Today’s Change
0.84
Today|||52-Week Range
7.78
-55.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues5.0M3.8M8.0M5.7M
 
 
 
 
 
Depreciation And Amortization56.0K31.0K20.0K29.0K
 
 
 
 
 
 
Operating ExpensesGross Income4.9M3.7M----
 
 
 
General Expenses30.8M38.3M39.7M50.7M
 
 
 
 
 
Research And Development22.6M29.2M28.9M27.7M
 
 
 
 
 
Total Operating Expenses30.9M38.4M39.7M50.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-25.9M-34.6M-31.8M-45.0M
 
 
 
 
 
Extraordinary Credit5.7M0.0096.0K3.9M
 
 
 
 
Extraordinary Charge0.00-7.5M----
 
 
Interest Expense On Debt--1.9M2.9M1.7M
 
 
 
 
Other Expenses0.0010.0K-4.0K-132.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-20.1M-44.0M-34.6M-43.0M
 
 
 
 
 
Net Income-20.1M-44.0M-34.6M-43.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS46.4M48.1M52.2M60.1M
 
 
 
 
 
Shares To Calculate EPS Diluted46.4M48.1M52.2M61.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.43-$0.91-$0.66-$0.76
 
 
 
 
 
EPS Diluted-$0.43-$0.91-$0.66-$0.76